Connection

Antonio Lalueza to Humans

This is a "connection" page, showing publications Antonio Lalueza has written about Humans.
Connection Strength

0.046
  1. Influence of viral load in the outcome of hospitalized patients with influenza virus infection. Eur J Clin Microbiol Infect Dis. 2019 Apr; 38(4):667-673.
    View in: PubMed
    Score: 0.006
  2. Impact of severe hematological abnormalities in the outcome of hospitalized patients with influenza virus infection. Eur J Clin Microbiol Infect Dis. 2017 Oct; 36(10):1827-1837.
    View in: PubMed
    Score: 0.006
  3. Ertapenem-induced neurological toxicity in a patient with stage IV chronic kidney disease. Enferm Infecc Microbiol Clin. 2017 11; 35(9):607-608.
    View in: PubMed
    Score: 0.006
  4. Cladosporium macrocarpum brain abscess after endoscopic ultrasound-guided celiac plexus block. Endoscopy. 2011; 43 Suppl 2 UCTN:E9-10.
    View in: PubMed
    Score: 0.004
  5. Mild AST elevation as an early sign of COVID-19 severity in a multicenter Madrid cohort. Rev Esp Enferm Dig. 2021 11; 113(11):780-786.
    View in: PubMed
    Score: 0.002
  6. Clinical Characteristics and Risk Factors of Respiratory Failure in a Cohort of Young Patients Requiring Hospital Admission with SARS-CoV2 Infection in Spain: Results of the Multicenter SEMI-COVID-19 Registry. J Gen Intern Med. 2021 10; 36(10):3080-3087.
    View in: PubMed
    Score: 0.002
  7. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study. Int J Infect Dis. 2021 Apr; 105:487-494.
    View in: PubMed
    Score: 0.002
  8. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression. Front Cell Infect Microbiol. 2021; 11:624483.
    View in: PubMed
    Score: 0.002
  9. Soluble fms-like tyrosine kinase-1: a potential early predictor of respiratory failure in COVID-19 patients. Clin Chem Lab Med. 2021 06 25; 59(7):e289-e292.
    View in: PubMed
    Score: 0.002
  10. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study. Int J Infect Dis. 2021 Apr; 105:319-325.
    View in: PubMed
    Score: 0.002
  11. Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study. J Infect. 2021 06; 82(6):276-316.
    View in: PubMed
    Score: 0.002
  12. Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021 Jun; 40(6):1209-1216.
    View in: PubMed
    Score: 0.002
  13. COVID-19 in solid organ transplant recipients: A single-center case series from Spain. Am J Transplant. 2020 07; 20(7):1849-1858.
    View in: PubMed
    Score: 0.002
  14. Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study. J Alzheimers Dis. 2020; 78(4):1367-1372.
    View in: PubMed
    Score: 0.002
  15. Impact on mortality of adherence to evidence-based interventions in patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus. Infect Dis (Lond). 2018 Nov - Dec; 50(11-12):837-846.
    View in: PubMed
    Score: 0.002
  16. Impact of functional status on 6-month mortality in elderly patients with acute venous thromboembolism: results from a prospective cohort. J Thromb Thrombolysis. 2018 Oct; 46(3):325-331.
    View in: PubMed
    Score: 0.002
  17. Human Herpesvirus 8-Associated Inflammatory Cytokine Syndrome. JAMA Dermatol. 2018 02 01; 154(2):228-230.
    View in: PubMed
    Score: 0.002
  18. Pathogen-related factors affecting outcome of catheter-related bacteremia due to methicillin-susceptible Staphylococcus aureus in a Spanish multicenter study. Eur J Clin Microbiol Infect Dis. 2017 Oct; 36(10):1757-1765.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.